论文信息 - HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib - 字舞流文

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib

H. Ji | F. Hirsch | P. Bunn | R. Doebele | D. Camidge | C. Rivard | Hui Yu | C. Zhou | Jun Zhang | T. Jiang | S. Ren | Caicun Zhou | G. Gao | S. Yang | M. Tu | T. Ng | J. Zhang | M. Tu | Yan Wang | Y. Wang | H. Ji | H. Yu | Shuo Yang | Z. Qin | J. Jiang | Q. Wang | C. Rivard | F. Hirsch | H. Ji | Z. Qin